Bilaketaren emaitzak - Bruce D. Cheson
- Erakusten 1 - 20 emaitzak -- 94
- Go to Next Page
-
1
Radioimmunotherapy of non-Hodgkin lymphomas nork Bruce D. Cheson
Argitaratua 2002Revisão -
2
How we manage follicular lymphoma nork Wolfgang Hiddemann, Bruce D. Cheson
Argitaratua 2014Revisão -
3
Diffuse large B-cell lymphoma: new targets and novel therapies nork Bruce D. Cheson, Grzegorz S. Nowakowski, Gilles Salles
Argitaratua 2021Revisão -
4
The role of FDG-PET scans in patients with lymphoma nork Pamela Seam, Malik E. Juweid, Bruce D. Cheson
Argitaratua 2007Revisão -
5
-
6
-
7
The origin of the chemiluminescence of phagocytosing granulocytes. nork Bruce D. Cheson, Ronald L. Christensen, R Sperling, Bern Kohler, Bernard Babior
Argitaratua 1976Artigo -
8
-
9
-
10
-
11
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification nork Bruce D. Cheson, Richard I. Fisher, Sally F. Barrington, Franco Cavalli, Lawrence H. Schwartz, Emanuele Zucca, Tim Lister
Argitaratua 2014Artigo -
12
Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients nork Guido Tricot, S Jagannath, David H. Vesole, J Nelson, Sharon Tindle, L.S. Miller, Bruce D. Cheson, John Crowley, Bart Barlogie
Argitaratua 1995Artigo -
13
-
14
Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront... nork M. S. Czuczman, John P. Leonard, Sin‐Ho Jung, Jeffrey L. Johnson, Eric D. Hsi, John C. Byrd, Bruce D. Cheson
Argitaratua 2012Artigo -
15
Autotransplants in multiple myeloma: what have we learned? nork DH Vesole, Guido Tricot, S Jagannath, K.R. Desikan, David S. Siegel, D Bracy, L.S. Miller, Bruce D. Cheson, John Crowley, Barthel Barlogie
Argitaratua 1996Artigo -
16
Phase I study of obatoclax mesylate (GX15-070), a small molecule pan–Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia nork Susan O’Brien, David F. Claxton, Michael Crump, Stefan Faderl, Thomas J. Kipps, Michael J. Keating, Jean Viallet, Bruce D. Cheson
Argitaratua 2008Artigo -
17
-
18
-
19
Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma nork Michael Crump, Bertrand Coiffier, Eric D. Jacobsen, Linda Sun, Justin L. Ricker, Huafeng Xie, Stanley R. Frankel, Sophia Randolph, Bruce D. Cheson
Argitaratua 2008Artigo -
20
Bilaketa egiteko lanabesak:
Antzeko gaiak
Medicine
Internal medicine
Oncology
Lymphoma
Chemotherapy
Gastroenterology
Rituximab
Surgery
Leukemia
Chronic lymphocytic leukemia
Immunology
Ibrutinib
Physics
Clinical trial
Multiple myeloma
Neutropenia
Adverse effect
Astrobiology
Biology
Cyclophosphamide
Refractory (planetary science)
Follicular lymphoma
Antibody
Vincristine
Nuclear medicine
Phases of clinical research
Idelalisib
Positron emission tomography
Transplantation
Diffuse large B-cell lymphoma